Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10-Reference-Cited by-同舟云学术

Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10

Published:2015-01-21 Issue:4 Volume:45 Page:999-1009
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Tao Huimin¹²,Lu Lin¹³,Xia Yang¹⁴,Dai Fu⁴,Wang Yi⁴,Bao Yangyi⁴,Lundy Steven K.⁵,Ito Fumito¹,Pan Qin⁶,Zhang Xiaolian⁶,Zheng Fang²,Shu Guoshun¹⁷,Fang Bingmu⁸,Jiang Jinhong⁸,Xia Jianchuang³,Huang Shiang²,Li Qiao¹⁴,Chang Alfred E.¹

Affiliation:

1. Department of Surgery; University of Michigan, ; Ann Arbor; MI USA

2. Hubei Province Stem Cell Research and Appling Center; Institute of Hematology, ; Union Hospital, ; Tongji Medical College, ; Huazhong University of Science and Technology; Wuhan China

3. State Key Laboratory of Oncology in Southern China and Department of Experimental Research; Sun Yat-sen University Cancer Center; Guangzhou China

4. The Third Affiliated Hospital of Anhui Medical University; Hefei China

5. Department of Internal Medicine; University of Michigan, ; Ann Arbor, MI, USA

6. Wuhan University School of Medicine; Wuhan China

7. Second Xiangya Hospital; Changsha China

8. Lishui People's Hospital of Zhejiang Province; China

Funder

NIH

National Science Fund of China

National Outstanding Youth Foundation of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201444625/fullpdf

Reference39 articles.

1. Cancer immunotherapy comes of age;Mellman;Nature,2011

2. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma;Ward;J. Immunol.,1988

3. Distinct immunologic specificity of tumor regression mediated by effector cells isolated from immunized and tumor-bearing mice;Chang;Cell Immunol.,1989

4. Generation of T cells reactive to the poorly immunogenic B16-BL6 melanoma with efficacy in the treatment of spontaneous metastases;Geiger;J. Immunother. Emphasis Tumor Immunol.,1993

5. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells;Li;J. Immunol.,2005

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic changes in B cell subpopulations in response to triple-negative breast cancer development;Scientific Reports;2024-05-21

2. Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib;Journal of Cancer Research and Clinical Oncology;2024-05-19

3. CD3 and CD20 Expressions and Infiltrating Patterns in Salivary Gland Tumors;Diagnostics;2024-05-03

4. Predictability of B cell clonal persistence and immunosurveillance in breast cancer;Nature Immunology;2024-05

5. Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics;Frontiers in Immunology;2024-03-12